Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 16/20 | 0.81 |
| ▸ | FLT3 | P36888 | 4/20 | 0.81 |
| ▸ | KIT | P10721 | 3/20 | 0.81 |
| ▸ | AURKA | O14965 | 2/20 | 0.81 |
| ▸ | EGFR | P00533 | 1/20 | 0.81 |
| ▸ | RET | P07949 | 1/20 | 0.81 |
| ▸ | MET | P08581 | 1/20 | 0.81 |
| ▸ | SRC | P12931 | 1/20 | 0.81 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.81 |
| ▸ | KDR | P35968 | 1/20 | 0.81 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.81 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.81 |
| ▸ | MERTK | Q12866 | 1/20 | 0.81 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.81 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.81 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2056553 | 1.00 | AXL (0.81) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL467836 | 1.00 | AXL (0.81) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL30090868 | 1.00 | AXL (0.81) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL1639408 | 0.92 | AXL (0.80) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL30090884 | 0.92 | AXL (0.80) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL20351831 | 0.92 | AXL (0.79) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL24821495 | 0.91 | AXL (0.79) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL24821441 | 0.91 | AXL (0.79) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL467844 | 0.91 | AXL (0.79) | AXLFLT3KITAURKAEGFR | |
| SCHEMBL24819579 | 0.91 | AXL (0.79) | AXLFLT3KITAURKAEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4138823-A1 | METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR | BerGenBio ASA (NO) | 2023-03-01 | — | — | EP | claimed |
| EP-4132652-A1 | AXL INHIBITORS FOR ANTIVIRAL THERAPY | BerGenBio ASA (NO) | 2023-02-15 | — | — | EP | claimed |
| EP-4125908-A1 | COMBINATION THERAPY COMPRISING AN AXL INHIBITOR | BerGenBio ASA (NO) | 2023-02-08 | — | — | EP | claimed |
| EP-4138823-A1 | METHOD OF SELECTING PATIENTS FOR TREATMENT WITH A COMBINATION OF AN AXL INHIBITOR AND AN IMMUNE CHECKPOINT MODULATOR | BerGenBio ASA (NO) | 2023-03-01 | — | — | EP | disclosed |
| EP-4132652-A1 | AXL INHIBITORS FOR ANTIVIRAL THERAPY | BerGenBio ASA (NO) | 2023-02-15 | — | — | EP | disclosed |
| EP-4125908-A1 | COMBINATION THERAPY COMPRISING AN AXL INHIBITOR | BerGenBio ASA (NO) | 2023-02-08 | — | — | EP | disclosed |